Similar articles

• PSA screening: the bottom line.

  Elhilali MM. Elhilali MM. CMAJ. 2000 Mar 21;162(6):791-2. CMAJ. 2000. PMID: 10750466 Free PMC article. No abstract available.
• How valuable is prostate-specific antigen screening?

  Handler S. Handler S. Minn Med. 1996 Jun;79(6):2. Minn Med. 1996. PMID: 8692130 No abstract available.
• Is an improved PSA screening test in sight?

  Savage L. Savage L. J Natl Cancer Inst. 2007 Oct 17;99(20):1503-4. doi: 10.1093/jnci/djm195. Epub 2007 Oct 9. J Natl Cancer Inst. 2007. PMID: 17925529 No abstract available.
• [The PSA test does not hold for screening. Good--but not good enough].

  Holmström B, Johansson M, Bratt O, Stattin P. Holmström B, et al. Lakartidningen. 2010 Feb 17-23;107(7):436, 438-9. Lakartidningen. 2010. PMID: 20384076 Review. Swedish. No abstract available.
• Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.

  Hernández J, Thompson IM. Hernández J, et al. Cancer. 2004 Sep 1;101(5):894-904. doi: 10.1002/cncr.20480. Cancer. 2004. PMID: 15329895 Review.